Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Repare Therapeutics Inc. - Common Shares
(NQ:
RPTX
)
1.830
-0.030 (-1.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
542,476
Open
1.830
Bid (Size)
1.780 (1)
Ask (Size)
1.820 (2)
Prev. Close
1.860
Today's Range
1.730 - 1.860
52wk Range
0.8900 - 4.069
Shares Outstanding
42,088,446
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 13, 2025
From
Repare Therapeutics Inc.
Via
Business Wire
Repare (RPTX) Q2 Loss Narrows 52%
August 08, 2025
Via
The Motley Fool
Performance
YTD
+38.6%
+38.6%
1 Month
+5.2%
+5.2%
3 Month
+20.4%
+20.4%
6 Month
+52.5%
+52.5%
1 Year
-46.5%
-46.5%
More News
Read More
Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
August 08, 2025
From
Repare Therapeutics Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 16, 2025
Via
Benzinga
Repare Therapeutics Jumps After Hours On $267M Global Licensing Deal With Debiopharm; Retail Traders Rush In
July 16, 2025
Via
Stocktwits
Why Data Storage Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket
July 16, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 15, 2025
Via
Benzinga
Tuesday's after hours session: top gainers and losers
July 15, 2025
Via
Chartmill
Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib
July 15, 2025
From
Repare Therapeutics Inc.
Via
Business Wire
Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2025 Financial Results
May 13, 2025
From
Repare Therapeutics Inc.
Via
Business Wire
Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics
May 01, 2025
From
Repare Therapeutics Inc.
Via
Business Wire
Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025
April 25, 2025
From
Repare Therapeutics Inc.
Via
Business Wire
Cathie Wood's Ark Invest Offloads Uipath, Prime Medicine, And Repare Therapeutics
April 11, 2025
Via
Benzinga
Cathie Wood's Ark Invest Loads Up On Amazon, Coinbase: Offloads UiPath, Roblox
April 04, 2025
Via
Benzinga
Cathie Wood Doubles Down: Mops Up Another $1.39 Million Worth Of Robinhood Stock Amid Trump Tariff Dip
April 03, 2025
Via
Benzinga
Topics
Government
Repare Therapeutics Announces Leadership Transitions
March 31, 2025
From
Repare Therapeutics Inc.
Via
Business Wire
Cathie Wood's Ark Invest Loads Up On Robinhood, Nvidia-Backed CoreWeave: Offloads Spotify, Roku
March 29, 2025
Via
Benzinga
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen
March 22, 2025
Via
Benzinga
Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta
March 15, 2025
Via
Benzinga
Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 07, 2025
From
Repare Therapeutics Inc.
Via
Business Wire
Gap To Rally Over 69%? Here Are 10 Top Analyst Forecasts For Friday
March 07, 2025
Via
Benzinga
Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results
March 03, 2025
From
Repare Therapeutics Inc.
Via
Business Wire
Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions
January 09, 2025
From
Repare Therapeutics Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 13, 2024
Via
Benzinga
Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet
December 13, 2024
Via
Benzinga
Frequently Asked Questions
Is Repare Therapeutics Inc. - Common Shares publicly traded?
Yes, Repare Therapeutics Inc. - Common Shares is publicly traded.
What exchange does Repare Therapeutics Inc. - Common Shares trade on?
Repare Therapeutics Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Repare Therapeutics Inc. - Common Shares?
The ticker symbol for Repare Therapeutics Inc. - Common Shares is RPTX on the Nasdaq Stock Market
What is the current price of Repare Therapeutics Inc. - Common Shares?
The current price of Repare Therapeutics Inc. - Common Shares is 1.830
When was Repare Therapeutics Inc. - Common Shares last traded?
The last trade of Repare Therapeutics Inc. - Common Shares was at 10/17/25 04:00 PM ET
What is the market capitalization of Repare Therapeutics Inc. - Common Shares?
The market capitalization of Repare Therapeutics Inc. - Common Shares is 77.02M
How many shares of Repare Therapeutics Inc. - Common Shares are outstanding?
Repare Therapeutics Inc. - Common Shares has 77M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.